PL2101574T3 - Związki i formulacje odpowiednie do wymiatania rodników - Google Patents

Związki i formulacje odpowiednie do wymiatania rodników

Info

Publication number
PL2101574T3
PL2101574T3 PL07864876T PL07864876T PL2101574T3 PL 2101574 T3 PL2101574 T3 PL 2101574T3 PL 07864876 T PL07864876 T PL 07864876T PL 07864876 T PL07864876 T PL 07864876T PL 2101574 T3 PL2101574 T3 PL 2101574T3
Authority
PL
Poland
Prior art keywords
compounds
formulations suitable
radical scavenging
scavenging
radical
Prior art date
Application number
PL07864876T
Other languages
English (en)
Inventor
David F. Kronholm
Alexander B. Sieval
Jan C. Hummelen
Original Assignee
Solenne Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solenne Bv filed Critical Solenne Bv
Publication of PL2101574T3 publication Critical patent/PL2101574T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/04—Ortho- or peri-condensed ring systems
    • C07D221/18—Ring systems of four or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/004—Aftersun preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52—Stabilizers
    • A61K2800/522—Antioxidants; Radical scavengers

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
PL07864876T 2006-11-29 2007-11-29 Związki i formulacje odpowiednie do wymiatania rodników PL2101574T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US86169706P 2006-11-29 2006-11-29

Publications (1)

Publication Number Publication Date
PL2101574T3 true PL2101574T3 (pl) 2017-01-31

Family

ID=39468711

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07864876T PL2101574T3 (pl) 2006-11-29 2007-11-29 Związki i formulacje odpowiednie do wymiatania rodników

Country Status (10)

Country Link
US (3) US8580810B2 (pl)
EP (1) EP2101574B1 (pl)
DK (1) DK2101574T3 (pl)
ES (1) ES2595054T3 (pl)
HU (1) HUE029669T2 (pl)
LT (1) LT2101574T (pl)
PL (1) PL2101574T3 (pl)
PT (1) PT2101574T (pl)
SI (1) SI2101574T1 (pl)
WO (1) WO2008067436A2 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI431002B (zh) 2011-05-30 2014-03-21 Ind Tech Res Inst 富勒烯衍生物與光電元件
US9226890B1 (en) 2013-12-10 2016-01-05 Englewood Lab, Llc Polysilicone base for scar treatment
US9685600B2 (en) 2015-02-18 2017-06-20 Savannah River Nuclear Solutions, Llc Enhanced superconductivity of fullerenes
WO2018099846A1 (de) * 2016-11-30 2018-06-07 Merck Patent Gmbh Verbindungen mit valerolaktam-strukturen
CN109125205A (zh) * 2018-08-16 2019-01-04 佛山市洵腾科技有限公司 一种抗衰老精华液及其制备方法
CN109232421B (zh) * 2018-09-20 2020-09-29 清华大学 苝单酰亚胺迫位稠合富勒烯类衍生物及其制备方法与应用
US12459081B2 (en) * 2018-10-09 2025-11-04 3M Innovative Properties Company Treated backing and coated abrasive article including the same
US20200188339A1 (en) 2018-12-14 2020-06-18 Max Champie Nutraceutical Composition Comprising C60 And Ketone Esters
US10709675B2 (en) 2018-12-14 2020-07-14 Max C. Champie Nutraceutical compositions comprising C60 and curcumin
US12274713B2 (en) 2021-05-07 2025-04-15 Max C. Champie Nutraceutical composition comprising a water-soluble fullerene and a ketone

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380703A (en) 1993-01-25 1995-01-10 The Research Foundation Of State University Of New York At Buffalo Halogen-doped superconductive fullerenes
US5648523A (en) 1995-10-26 1997-07-15 Chiang Long Y Fullerene derivatives as free-radical scavengers
JP2002193606A (ja) 2000-12-22 2002-07-10 Nec Corp 超伝導材料及びその製造方法
JP3541221B2 (ja) 2001-02-28 2004-07-07 独立行政法人産業技術総合研究所 アザフラ−レンの製造方法及び精製方法
US20050058675A1 (en) 2003-04-10 2005-03-17 Wilson Stephen R. Fullerene compositions for ameliorating dermatological conditions
TW200512007A (en) * 2003-05-30 2005-04-01 Fullerene Internat Corp Cosmetic compositions containing fullerene clusters
JP2007513977A (ja) 2003-12-15 2007-05-31 ナノ−シー，インク． ラジカル・スカベンジャーとして有用な高フラーレン
GB0413398D0 (en) 2004-06-16 2004-07-21 Koninkl Philips Electronics Nv Electronic device

Also Published As

Publication number Publication date
SI2101574T1 (sl) 2016-11-30
US10239839B2 (en) 2019-03-26
US8580810B2 (en) 2013-11-12
ES2595054T3 (es) 2016-12-27
EP2101574B1 (en) 2016-07-13
DK2101574T3 (en) 2016-09-12
US20100249168A1 (en) 2010-09-30
HUE029669T2 (hu) 2017-03-28
EP2101574A2 (en) 2009-09-23
WO2008067436A3 (en) 2008-07-17
LT2101574T (lt) 2016-10-25
US20170037012A1 (en) 2017-02-09
EP2101574A4 (en) 2011-06-22
US9475810B2 (en) 2016-10-25
US20140080853A1 (en) 2014-03-20
WO2008067436A2 (en) 2008-06-05
PT2101574T (pt) 2016-10-11

Similar Documents

Publication Publication Date Title
GB2435419B (en) Formulations
EP2046930A4 (en) FORMULATIONS BASED ON RHAMNOLIPIDS
IL195619A0 (en) Compositions and methods for joininig non-conjoined iumens
EP2101574A4 (en) COMPOUNDS AND FORMULATIONS FOR RADICAL RECEIVERS
GB0617575D0 (en) Herbicidal compounds and compositions
EP2004626A4 (en) BENZIMIDAZOLYL-PYRIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND IMMUNE DISORDERS
EP2001476A4 (en) BENZOIMIDAZOLYL-PARAZINE-BASED COMPOUNDS FOR INFLAMMATION USES AND IMMUNE DISORDERS
EP2086326A4 (en) CYCLOHEXENYL-ARYL COMPOUNDS AGAINST INFLAMMATION AND IMMUNE-SPECIFIC DISEASES
EP1848659A4 (en) DESOXYGENANT COMPOSITIONS AND PACKAGES COMPRISING SAID COMPOSITIONS
IL194899A0 (en) Amino-ethyl-amino-aryl (aeaa) compounds and their use
IL194366A0 (en) Solid dosage formulations
GB0718409D0 (en) Formulations
GB0605780D0 (en) Formulations
ZA200806361B (en) Methods and compositions for treating feline hyperthyroidism
GB0615213D0 (en) Fungicidal compounds and compositions
SI2497780T1 (sl) Spojine, povezane s TDF, in njihovi analogi
IL198760A0 (en) Oral formulations
GB0610336D0 (en) Formulations
GB0615108D0 (en) Novel formulations
EP2188231A4 (en) OXYGEN ABSORBING COMPOSITION
GB0525093D0 (en) Veterinary composition
GB0718404D0 (en) Formulations
GB0424051D0 (en) Compounds and compositions
IL192820A0 (en) Novel compounds and use thereof
GB0508991D0 (en) Veterinary composition